Transcatheter balloon valvuloplasty is established as the preferred treatment for congenital pulmonary and aortic valve stenosis in pediatric patients.
Supports transcatheter valvuloplasty preference in congenital stenosis; leaves open need for updated comparative trials.
Transcatheter balloon valvuloplasty has been used in pediatric cardiology since the mid‐80s. This procedure requires specific devices and equipment, especially in cases involving newborn infants. The risk is currently low, because of improvements in technology and catheterization laboratory equipment. The results are good enough to make transcatheter dilatation the treatment of choice for congenital stenosis of pulmonary and aortic valves.
No takes yet. Share an insight, caveat, or question.
JEAN‐FRANÇOIS PIÉCHAUD (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: